BioCentury | Jan 31, 2020
Distillery Therapeutics

Inhibiting SPK2 to treat Middle East respiratory syndrome

...online Dec. 18, 2019 doi:10.1038/s41467-019-13659-4 CONTACT: Theo Rein, Max Planck Institute of Psychiatry, Munich, Germany; Ludwig Maximilians University of Munich...
BioCentury | Dec 3, 2019
Financial News

Dec. 2 Financial Quick Takes: Kodiak gains on royalty deal; plus Clover, Aslan, Transcenta, EOC, Hui-Gene and ViGeneron

...GmbH raised an undisclosed series A round led by WuXi AppTec and Sequoia Capital. The Ludwig Maximilians University of Munich...
BioCentury | Sep 6, 2019
Company News

Management tracks: Prometheus, Step, Spero, NorthSea, Aristea, MODAG and more

Salix’s Mark McKenna will become CEO of gastroenterology and autoimmune disease company Prometheus Biosciences Inc. (San Diego, Calif.), formerly known as Precision IBD Inc. McKenna was president at Salix Pharmaceuticals Ltd., a subsidiary of Bausch...
BioCentury | Aug 29, 2019
Preclinical News

Aug. 29 Preclinical Quick Takes: New targets for leukemia from Calico and stroke from Gero; predictors of checkpoint inhibitor response and more

...of efficacy for HIV vaccines. TREM2 linked to protection against cognitive decline in Alzheimer's A Ludwig Maximilians University of Munich...
...Triggering receptor expressed on myeloid cells 2 BioCentury Staff Calico Life Sciences LLC Fudan University German Center for Neurodegenerative Diseases Ludwig Maximilians University of Munich National...
BioCentury | May 20, 2019
Distillery Therapeutics

HIST4H4 inhibition to treat atherosclerosis

...published online May 1, 2019 doi:10.1038/s41586-019-1167-6 CONTACT: Oliver Soehnlein, Ludwig Maximilians University of Munich, Munich, Germany email: oliver.soehnlein@gmail.com Claire Quang Ludwig Maximilians University of Munich Histone...
BioCentury | Jan 30, 2019
Distillery Therapeutics

Neurology; cardiovascular

...C. et al. Nat. Med. ; published online Jan. 28, 2019 doi:10.1038/s41591-018-0336-8 CONTACT: Changjun Yin, Ludwig Maximilians University of Munich...
...email: christine.skerka@hki-jena.de Claire Quang Easemedcontrol R&D GmbH & Co. KG Leibniz Institute for Natural Product Research and Infection Biology Ludwig Maximilians University of Munich Complement...
BioCentury | Jan 23, 2019
Distillery Techniques

Disease models

...C. et al. Nat. Commun. ; published online Jan. 10, 2019 doi:10.1038/s41467-018-08003-1 CONTACT: Elisabeth Reiser, Ludwig Maximilians University of Munich...
...as above email: andreas.dendorfer@med.uni-muenchen.de CONTACT: Rene Schramm, Ruhr University Bochum, Bad Oeynhausen, Germany email: rschramm@hdz-nrw.de Claire Quang Ludwig Maximilians University of Munich Ruhr...
BioCentury | Nov 30, 2018
Targets & Mechanisms

Adhesion targets emerge at ASH 2018

...PARP-14 could help treat signal transducer and activator of transcription 6 (STAT6)-mutant follicular lymphoma (FL). Ludwig Maximilians University of Munich...
BioCentury | Nov 1, 2018
Emerging Company Profile

Secarna’s next-gen oligos

...of Marburg, Karolinska Institute, University of Paris-Diderot, H. Lee Moffitt Cancer Center and Research Institute, Ludwig Maximilians University of Munich...
BioCentury | Jun 14, 2018
Translation in Brief

There’s more to MIF

...said. However, both he and co-author Jürgen Bernhagen, professor and chair of vascular biology at Ludwig Maximilians University of Munich...
Items per page:
1 - 10 of 84
BioCentury | Jan 31, 2020
Distillery Therapeutics

Inhibiting SPK2 to treat Middle East respiratory syndrome

...online Dec. 18, 2019 doi:10.1038/s41467-019-13659-4 CONTACT: Theo Rein, Max Planck Institute of Psychiatry, Munich, Germany; Ludwig Maximilians University of Munich...
BioCentury | Dec 3, 2019
Financial News

Dec. 2 Financial Quick Takes: Kodiak gains on royalty deal; plus Clover, Aslan, Transcenta, EOC, Hui-Gene and ViGeneron

...GmbH raised an undisclosed series A round led by WuXi AppTec and Sequoia Capital. The Ludwig Maximilians University of Munich...
BioCentury | Sep 6, 2019
Company News

Management tracks: Prometheus, Step, Spero, NorthSea, Aristea, MODAG and more

Salix’s Mark McKenna will become CEO of gastroenterology and autoimmune disease company Prometheus Biosciences Inc. (San Diego, Calif.), formerly known as Precision IBD Inc. McKenna was president at Salix Pharmaceuticals Ltd., a subsidiary of Bausch...
BioCentury | Aug 29, 2019
Preclinical News

Aug. 29 Preclinical Quick Takes: New targets for leukemia from Calico and stroke from Gero; predictors of checkpoint inhibitor response and more

...of efficacy for HIV vaccines. TREM2 linked to protection against cognitive decline in Alzheimer's A Ludwig Maximilians University of Munich...
...Triggering receptor expressed on myeloid cells 2 BioCentury Staff Calico Life Sciences LLC Fudan University German Center for Neurodegenerative Diseases Ludwig Maximilians University of Munich National...
BioCentury | May 20, 2019
Distillery Therapeutics

HIST4H4 inhibition to treat atherosclerosis

...published online May 1, 2019 doi:10.1038/s41586-019-1167-6 CONTACT: Oliver Soehnlein, Ludwig Maximilians University of Munich, Munich, Germany email: oliver.soehnlein@gmail.com Claire Quang Ludwig Maximilians University of Munich Histone...
BioCentury | Jan 30, 2019
Distillery Therapeutics

Neurology; cardiovascular

...C. et al. Nat. Med. ; published online Jan. 28, 2019 doi:10.1038/s41591-018-0336-8 CONTACT: Changjun Yin, Ludwig Maximilians University of Munich...
...email: christine.skerka@hki-jena.de Claire Quang Easemedcontrol R&D GmbH & Co. KG Leibniz Institute for Natural Product Research and Infection Biology Ludwig Maximilians University of Munich Complement...
BioCentury | Jan 23, 2019
Distillery Techniques

Disease models

...C. et al. Nat. Commun. ; published online Jan. 10, 2019 doi:10.1038/s41467-018-08003-1 CONTACT: Elisabeth Reiser, Ludwig Maximilians University of Munich...
...as above email: andreas.dendorfer@med.uni-muenchen.de CONTACT: Rene Schramm, Ruhr University Bochum, Bad Oeynhausen, Germany email: rschramm@hdz-nrw.de Claire Quang Ludwig Maximilians University of Munich Ruhr...
BioCentury | Nov 30, 2018
Targets & Mechanisms

Adhesion targets emerge at ASH 2018

...PARP-14 could help treat signal transducer and activator of transcription 6 (STAT6)-mutant follicular lymphoma (FL). Ludwig Maximilians University of Munich...
BioCentury | Nov 1, 2018
Emerging Company Profile

Secarna’s next-gen oligos

...of Marburg, Karolinska Institute, University of Paris-Diderot, H. Lee Moffitt Cancer Center and Research Institute, Ludwig Maximilians University of Munich...
BioCentury | Jun 14, 2018
Translation in Brief

There’s more to MIF

...said. However, both he and co-author Jürgen Bernhagen, professor and chair of vascular biology at Ludwig Maximilians University of Munich...
Items per page:
1 - 10 of 84